Investor Presentaiton slide image

Investor Presentaiton

16 Cytiva's Progress Since Acquisition KEY PRIORITIES & PROGRESS SINCE ACQUISITION Stand-up & Brand Establishment >200 TRANSITION SERVICES >3,000 #2 AGREEMENTS EXITED ASSOCIATES HIRED BRAND POWER & PREMIUM VS PEERS (CERNER ENVIZA) Embracing >400 DBS Capacity MANUFACTURING KAIZENS 2021 & 2022 Expansion & >$1.5B Investments cytiva RESULTS SINCE ACQUISITION AT ACQ. 2022 Revenue ~$3B >$6B Anticipated long-term +6-7% +HSD 2X IMPROVEMENT IN PROJECT OTD WITHIN FIRST YEAR core revenue growth ROIC +DD PLANNED CAPACITY INVESTMENT AT PALL & CYTIVA 2021-2025 >2X OUTPUT OF SUT PRODUCTS Exceeding our expectations on all fronts DANAHER
View entire presentation